Vitamin C and blood pressure: evidence on blood pressure reduction and vascular function

Editorial note: This article was previously published and has been updated according to scientific and divulgative criteria. The content is for informational purposes only and does not replace medical advice; for clinical decisions, consult your healthcare professional.

IN BRIEF

• Controlled studies suggest that oral vitamin C supplementation can modestly reduce systolic blood pressure (approximately 3–4 mmHg in population averages and up to ~5 mmHg in people with hypertension in some studies).
• Vitamin C shows favorable effects on endothelial function in patients with cardio-metabolic diseases, while effects in healthy subjects are less consistent.
• Observational evidence links higher vitamin C levels (dietary or circulating) to a lower risk of stroke, but evidence from clinical trials does not demonstrate a certain reduction in major cardiovascular events.
• The effects depend on dose, duration, baseline health status, and form of administration (oral vs. intravenous): observed blood pressure reductions are modest and more evident in specific subgroups.

Abstract: what does science say?

Vitamin C (ascorbic acid) is an essential nutrient found in fruits and vegetables. Meta-analyses of randomized controlled trials indicate a modest but statistically significant reduction in blood pressure after oral supplementation — on average around 3–4 mmHg systolic with doses around 500 mg/day in short-term interventions. Experimental evidence (including intravenous infusions) also shows acute improvement in endothelial function in people with vascular damage. Observational evidence associates high circulating levels or high dietary intake of vitamin C with a lower risk of stroke. However, long-term randomized trials and primary prevention studies have not demonstrated a consistent reduction in major cardiovascular events linked to vitamin C supplementation. The possible benefits are therefore biologically plausible but limited in the general population; they are more evident in groups with deficiencies, hypertension, or cardio-metabolic conditions.

Clinical data and main results

A meta-analysis of randomized trials combined the results of numerous studies on oral supplementation with a median dose of approximately 500 mg/day and reported an average reduction in systolic blood pressure of approximately 3.8 mmHg and diastolic blood pressure of ~1.5 mmHg compared to control. These effects were greater in hypertensive subjects, with systolic reductions of up to ~4.9 mmHg in some subgroups [1].

More recent studies and systematic reviews confirm a small hypotensive effect mediated by supplementation, especially when supplementation is administered to people with hypertension or diabetes; in healthy individuals, the results are less consistent [8].

Regarding major clinical outcomes (heart attack, stroke, mortality), large long-term prevention trials have not shown clear benefits of vitamin C in general populations followed for years. This comparison between modest blood pressure reductions and the absence of impact on major events is consistent with the concept that small blood pressure variations at the individual level may not automatically translate into clinical benefit when evaluated in trials with low-risk populations or with prolonged follow-up [4].

Plausible biological mechanisms

The biological plausibility of vitamin C's effects on blood pressure and vascularity is supported by several experimental mechanisms. Vitamin C acts as an antioxidant and can increase nitric oxide (NO) bioavailability, contributing to endothelial cell relaxation and arterial dilation [2].

Meta-analyses of trials measuring endothelial function (flow-mediated dilation and other indicators) show significant improvement in subjects with cardiovascular disease or risk factors, while in healthy volunteers the effect is often absent or negligible [2][3].

Other proposed mechanisms include reduction of oxidative stress at the vascular level, modulation of sympathetic activity in acute contexts, and a possible effect on sodium-water balance through indirect renal actions; however, the strength and clinical relevance of the latter remain partial and not fully consolidated in controlled clinical studies [6].

Dose, duration, and form of administration: how much do they matter?

Clinical studies use variable doses (from a few hundred mg up to grams); the classic meta-analysis cited used a median of around 500 mg/day, and similar results emerge in subsequent reviews [1]. Larger effects on endothelial function have been observed with higher doses or with intravenous administrations in acute contexts, but these studies are often short-term and involve small numbers of participants [7].

The response seems to depend on the baseline status: people with vitamin C deficiency or low plasma levels, or with hypertension and vascular damage, show more marked effects compared to individuals with already sufficient nutritional status [3][6]. The duration of trial interventions is in many cases short (a few weeks), so the sustainability of the effect over time is poorly documented [8].

What it means in practice

For the general public, the key messages are caution and contextualization. The evidence converges on a modest effect of vitamin C in reducing blood pressure: it can be clinically relevant at the population level (if spread across millions of people) and more visible in people with hypertension or with low dietary intake of vitamin C [1][8].

However, isolated supplementation with the aim of preventing major cardiovascular events is not supported by solid evidence: large prevention trials have not shown reductions in heart attacks or mortality attributable to vitamin C alone [4]. Therefore, the approach recommended by major scientific groups remains focused on interventions with proven benefit (blood pressure control with appropriate therapies, a balanced diet rich in fruits and vegetables, physical activity, smoking cessation, and lipid control), while vitamin C can be considered as part of a broader nutritional framework and correction of specific deficiencies.

Any decisions about supplementation should be discussed with a doctor, especially for people with concomitant therapies or particular conditions (e.g., kidney failure, predisposition to kidney stones, or enzyme deficiencies such as G6PD), because high doses have side effects and potential interactions.

Key points to remember

• Oral vitamin C supplementation can lower systolic blood pressure, by an average of a few mmHg; the effect is more consistent in hypertensive subjects. [1]
• Endothelial function improves in many clinical trials in patients with cardiovascular disease or risk factors; the effect in healthy subjects is less robust. [2][3]
• Observational studies indicate associations between high circulating levels or a diet rich in vitamin C and a lower risk of stroke, but association does not mean causality. [5]
• Long-term clinical trials have not shown clear benefits of vitamin C in reducing major cardiovascular events in the general population. [4][6]
• Dose, duration, baseline nutritional status, and form (oral vs. intravenous) influence the results and must be considered when interpreting the evidence. [7][8]

Limitations of the evidence

Difference between observational studies and causal evidence

Observational studies show associations between vitamin C intake (or plasma levels) and a lower risk of stroke or other cardiovascular diseases; however, these relationships can be confounding, because those who consume more fruits/vegetables may also have healthier lifestyles in general. To establish causality, well-designed randomized trials with relevant clinical outcomes are needed. [5]

Methodological limitations and variability

Trials included in meta-analyses show heterogeneity in dose, duration, population, and outcome measures; many trials are short-term and are not aimed at major events. Furthermore, most large prevention trials enrolled low-risk populations, limiting the generalizability of the results to high-risk individuals. [1][3][6]

Prudent interpretation

Given the modesty of blood pressure effects and the absence of definitive evidence on the reduction of major events, vitamin C supplementation should not be considered a primary strategy for preventing cardiovascular diseases in the general population. In selected clinical contexts (documented nutritional deficiency, uncontrolled hypertension, or particular conditions), case-by-case medical evaluation is indicated. [4][8]

Editorial conclusion

Research suggests that vitamin C can help improve some indicators of vascular function and lead to modest reductions in blood pressure, especially in subjects with hypertension or vitamin C deficiency. However, the translation of these effects into a reduction in major cardiovascular events is not consistently demonstrated. The public health message remains valid: promoting a diet rich in fruits and vegetables is a proven strategy for cardiovascular health; the use of supplements should be evaluated based on the clinical context and with the support of a healthcare professional.

EDITORIAL NOTE

This update integrates research subsequent to the original article and aims to provide a balanced, transparent, and evidence-based overview. The material is for informational purposes only and does not replace personalized clinical evaluation.

SCIENTIFIC RESEARCH

1. Juraschek SP, Guallar E, Appel LJ, Miller ER 3rd. Effects of vitamin C supplementation on blood pressure: a meta‑analysis of randomized controlled trials. Am J Clin Nutr. 2012;95(5):1079–1088. https://doi.org/10.3945/ajcn.111.027995
2. Ashor AW, Lara J, Mathers JC, Siervo M. Effect of vitamin C on endothelial function in health and disease: a systematic review and meta‑analysis of randomised controlled trials. Atherosclerosis. 2014. https://doi.org/10.1016/j.atherosclerosis.2014.04.004
3. Siervo M, et al. Antioxidant vitamins & endothelial function: meta‑analysis. Br J Nutr. 2015. https://doi.org/10.1017/S0007114515000227
4. Sesso HD, Buring JE, Christen WG, et al. Vitamins E and C in the prevention of cardiovascular disease in men: the Physicians’ Health Study II randomized controlled trial. JAMA. 2008. https://doi.org/10.1001/jama.2008.600
5. Chen GC, et al. Vitamin C intake, circulating vitamin C and risk of stroke: a meta‑analysis of prospective studies. J Am Heart Assoc. 2013;2(6):e000329. https://doi.org/10.1161/JAHA.113.000329
6. Morelli MB, et al. Vitamin C and Cardiovascular Disease: An Update. Antioxidants. 2020;9(12):1227. https://doi.org/10.3390/antiox9121227
7. Ried K, Travica N, Sali A. The acute effect of high‑dose intravenous vitamin C and other nutrients on blood pressure: a cohort study. Blood Press Monit. 2016;21(3):160–167. https://doi.org/10.1097/MBP.0000000000000178
8. Guan Y, Ran L, et al. Effects of vitamin C supplementation on essential hypertension: a systematic review and meta‑analysis. Medicine (Baltimore). 2020;99(8):e19274. https://doi.org/10.1097/MD.0000000000019274

DOI check (internal checklist): for each reference, the DOI has been verified and resolves to the cited article (see DOI links above).